Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice
==================================================================================================================================================================================================================================================================

* Yaya Chu
* Gaurav Nayyar
* Susiyan Jiang
* Jeremy M. Rosenblum
* Patrick Soon-Shiong
* Jeffrey T Safrit
* Dean A. Lee
* Mitchell S. Cairo